Inflammation promotes resistance to immune checkpoint inhibitors in high microsatellite instability colorectal cancer

HIGHLIGHTS

• who: Qiaoqi Sui from the Patient inclusion and follow-up Patients diagnosed with MSI-H CRC from Sun Yat-sen University Cancer Center (SYSUCC, Guangzhou, China), who started to receive , blockade therapy from January , to October , were retrospectively enrolledThe inclusion criteria were as follows: (1) pathologically diagnosed colorectal cancer have published the research work: Inflammation promotes resistance to immune checkpoint inhibitors in high microsatellite instability colorectal cancer, in the Journal: (JOURNAL) of 12/09/2021
• what: The authors show that in a patient with high microsatellite instability (MSI-H) CRC and a local inflammatory condition . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.